Hims Hers Health Inc Net Assets
Hims Hers Health Inc net assets. Based on the latest financial reports, Hims Hers Health Inc (HIMS) has net assets worth $324.07 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.63 Billion) and total liabilities ($3.30 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Hims Hers Health Inc (HIMS) equity growth momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $324.07 Million |
| % of Total Assets | 8.93% |
| Annual Growth Rate | 57.2% |
| 5-Year Change | 61.65% |
| 10-Year Change | N/A |
| Growth Volatility | 283.35 |
Net Assets of Hims Hers Health Inc (2018–2025)
Net assets of Hims Hers Health Inc from 2018 to 2025. This chart illustrates how Hims Hers Health Inc's net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Hims Hers Health Inc to measure how much of total assets are equity-financed.
Annual Net Assets for Hims Hers Health Inc (2018–2025)
The table below shows the annual net assets of Hims Hers Health Inc from 2018 to 2025. For live market cap and overall valuation, see Hims Hers Health Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $540.93 Million | +13.47% |
| 2024-12-31 | $476.72 Million | +38.57% |
| 2023-12-31 | $344.03 Million | +10.36% |
| 2022-12-31 | $311.74 Million | -6.84% |
| 2021-12-31 | $334.62 Million | +327.83% |
| 2020-12-31 | $-146.87 Million | -8.56% |
| 2019-12-31 | $-135.29 Million | -693.55% |
| 2018-12-31 | $22.79 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hims Hers Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3265800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Hims Hers Health Inc Net Assets Breakdown (December 2025)
Hims Hers Health Inc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $23.00K | 0.00% |
| Other Comprehensive Income | $2.29 Million | 0.42% |
| Other Components | $652.38 Million | 120.60% |
| Total Equity | $540.93 Million | 100.00% |
Hims Hers Health Inc Competitors by Market Cap
The table below lists competitors of Hims Hers Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Youngor Group Co Ltd
SHG:600177
|
$5.78 Billion |
|
Silergy Corp
TW:6415
|
$5.79 Billion |
|
Ormat Technologies Inc
NYSE:ORA
|
$5.79 Billion |
|
Taiwan Business Bank
TW:2834
|
$5.80 Billion |
|
Clal Insurance Enterprises Holdings Ltd
TA:CLIS
|
$5.78 Billion |
|
Posco International Corp
KO:047050
|
$5.78 Billion |
|
China Oilfield Services Ltd Class A
SHG:601808
|
$5.77 Billion |
|
Flughafen Zurich
SW:FHZN
|
$5.77 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hims Hers Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 476,716,000 to 540,928,000, a change of 64,212,000 (13.5%).
- Net income of 128,365,000 contributed positively to equity growth.
- Share repurchases of 89,960,000 reduced equity.
- Other comprehensive income increased equity by 2,618,000.
- Other factors increased equity by 23,189,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $128.37 Million | +23.73% |
| Share Repurchases | $89.96 Million | -16.63% |
| Other Comprehensive Income | $2.62 Million | +0.48% |
| Other Changes | $23.19 Million | +4.29% |
| Total Change | $- | 13.47% |
Book Value vs Market Value Analysis
This analysis compares Hims Hers Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.27x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 75.87x to 12.27x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $0.34 | $25.70 | x |
| 2019-12-31 | $-3.89 | $25.70 | x |
| 2020-12-31 | $-4.15 | $25.70 | x |
| 2021-12-31 | $1.79 | $25.70 | x |
| 2022-12-31 | $1.52 | $25.70 | x |
| 2023-12-31 | $1.64 | $25.70 | x |
| 2024-12-31 | $2.01 | $25.70 | x |
| 2025-12-31 | $2.09 | $25.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hims Hers Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.73%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.47%
- • Asset Turnover: 1.09x
- • Equity Multiplier: 3.98x
- Recent ROE (23.73%) is above the historical average (-42.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -330.10% | -282.03% | 0.56x | 2.08x | $-77.52 Million |
| 2019 | 0.00% | -87.29% | 1.15x | 0.00x | $-58.53 Million |
| 2020 | 0.00% | -12.18% | 1.25x | 0.00x | $-3.43 Million |
| 2021 | -32.17% | -39.60% | 0.65x | 1.26x | $-141.12 Million |
| 2022 | -21.07% | -12.46% | 1.44x | 1.18x | $-96.85 Million |
| 2023 | -6.84% | -2.70% | 1.98x | 1.28x | $-57.95 Million |
| 2024 | 26.44% | 8.54% | 2.09x | 1.48x | $78.37 Million |
| 2025 | 23.73% | 5.47% | 1.09x | 3.98x | $74.27 Million |
Industry Comparison
This section compares Hims Hers Health Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $86,713,726
- Average return on equity (ROE) among peers: 26.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hims Hers Health Inc (HIMS) | $324.07 Million | -330.10% | 10.20x | $5.78 Billion |
| Aurora Cannabis Inc (ACB) | $1.71 Million | -2.57% | 0.01x | $236.15 Million |
| ADC Therapeutics SA (ADCT) | $335.50 Million | -73.41% | 0.53x | $143.73 Million |
| Akanda Corp (AKAN) | $4.28 Million | -95.78% | 0.85x | $584.11K |
| Akebia Ther (AKBA) | $74.01 Million | -330.87% | 6.15x | $194.43 Million |
| Alkermes Plc (ALKS) | $18.84 Million | -398.98% | 9.71x | $7.67 Billion |
| Amylyx Pharmaceuticals Inc (AMLX) | $-151.17 Million | 0.00% | 0.00x | $3.25 Billion |
| Amphastar P (AMPH) | $233.44 Million | 7.75% | 0.36x | $980.07 Million |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $5.96 Million | 1208.40% | 615.85x | $5.92 Billion |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $208.93 Million | -62.22% | 17.18x | $3.57 Billion |
| Anika Therapeutics Inc (ANIK) | $135.63 Million | 15.17% | 0.15x | $260.30 Million |
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available … Read more